Voloridge Investment Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Voloridge Investment Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-60,877	Closed	-$3.25M	–	465
2016 Q1	$3.25M	Buy	+60,877	New	+$4.49M	0.08%	178
2015 Q4	–	Sell	-34,270	Closed	-$4.03M	–	385
2015 Q3	$4.03M	Buy	+34,270	New	+$4.48M	0.19%	128
2015 Q2	–	Sell	-14,435	Closed	-$835K	–	432
2015 Q1	$835K	Buy	+14,435	New	+$613K	0.04%	220

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Voloridge Investment Management's ANAC Position: Q2 2016 in Review

Voloridge Investment Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 60,877 shares — an estimated $3.25M sold.

Voloridge Investment Management first reported a position in ANAC in Q1 2015 and held it in 3 quarters. The position peaked at $4.03M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Voloridge Investment Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Voloridge Investment Management sold 60,877 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $3.25M.
Voloridge Investment Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 3 quarters.
Voloridge Investment Management's ANACOR PHARMACEUTICALS INC COM position peaked at $4.03M in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Voloridge Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.